G3BP1 and neoplasm: Meanwhile, no significant (p > 0.05) associations were identified between the expression of G3BP1 and any other clinicopathological characteristics, including patient’s age, gender, RCC subtype, tumor size, tumor side, and necrosis (Table 1).